As shown in Figs. 3G and  EV3G, UBQLN2 immunoreactivity was clearly observed in LBs in the substantia nigra of four sporadic PD patients, whereas background signal was barely detectable in the control IgG. This evidence concerns the gene UBQLN2 and Parkinson disease.